Navigation Links
Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Date:4/26/2012

eater than or equal to 10 percent of Vimpat® -treated patients, and greater than placebo, were dizziness, headache, nausea and diplopia.  Additional important safety information for Vimpat® is available at the end of the press release.

In the European Union, Vimpat® (film-coated tablets and solution for infusion) is approved as adjunctive therapy for the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy, aged 16 years and older.  Vimpat® solution for infusion may be used when oral administration is temporarily not feasible.

The maximum recommended daily dose for Vimpat® in the European Union and the U.S. is 400 mg/day.

Important safety information about Vimpat® in the U.S.

Warnings and Precautions
AEDs increase the risk of suicidal behavior and ideation. Patients taking Vimpat® should be monitored for the emergence or worsening of depression, suicidal thoughts or behavior, and/or any unusual changes in mood or behavior.

Patients should be advised that Vimpat® may cause dizziness, ataxia, and syncope. Caution is advised for patients with known cardiac conduction problems, who are taking drugs known to induce PR interval prolongation, or with severe cardiac disease. In patients with seizure disorders, Vimpat® should be gradually withdrawn to minimize the potential of increased seizure frequency. Multi-organ hypersensitivity reactions have been reported with antiepileptic drugs. If this reaction is suspected, treatment with Vimpat® should be discontinued.

Vimpat® oral solution contains aspartame, a source of phenylalanine. A 200 mg dose of Vimpat® oral solution (equivalent to 20 mL) contains 0.32 mg of phenylalanine.

Common Adverse Reactions
The most common adverse reactions occurring in greater than or equal to 10 percent of Vimpat®-t
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
3. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
4. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
5. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
6. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
7. Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
8. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
9. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
10. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
11. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015  An effective advisory ... provide non-binding but informed guidance to pharmaceutical organizations ... on investment, it is important for leaders to ... resources. Research and consulting leader ... assist pharmaceutical and medical device executives in identifying ...
(Date:5/1/2015)... /PRNewswire/ --Research and Markets ( http://www.researchandmarkets.com/research/vzcw2v/americas_clinical ) ... Analyzer Market by Product, by End-Users - Forecast to 2019" ... Chemistry Analyzers market is estimated to grow at a CAGR ... U.S., Canada , Mexico ... (RoA) are covered in this report. The Americas ...
(Date:5/1/2015)... , May 1, 2015 Following yesterday,s release of ... D, here are five things you need to know: ... market-based structure is unique among government programs. ... D is different than other parts of Medicare and other ... that submit bids to offer prescription drug benefits to enrollees. ...
Breaking Medicine Technology:New Study Presents Insights to Advisory Board Effectiveness in the Pharmaceutical Sector 2Americas Clinical Chemistry Analyzer (Semi-Automated Clinical Chemistry and Fully-Automated Clinical Chemistry) Market - Forecast to 2019 25 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3
(Date:5/3/2015)... Clarkston, Metamora, Michigan (PRWEB) May 03, 2015 ... ‘Like’ mark on their Facebook page. , ... patients on the many services the Practice has, it’s ... current events. , Women’s Excellence has a very strong ... +, Pinterest, Instagram and You Tube. , Women’s ...
(Date:5/3/2015)... Bubbly Walrus ” was featured on NewsWatch as part of ... and coolest applications on the market for iOS, Android, and ... conducted the app review and shared with viewers how this ... to play on smartphones are the ones that get users ... a video game that just absorbs attention, why not exercise ...
(Date:5/3/2015)... LOUIS, Missouri (PRWEB) May 03, 2015 ... international business that will directly impact your career? ... is designed for dynamic leaders in multinational companies ... multinational company. In a changing global landscape, differences ... negotiations and relationships. The EMIB program develops the ...
(Date:5/3/2015)... Hanover, MA (PRWEB) May 03, 2015 It is ... 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been ... of Lissa organized this great family-friendly event to honor her loving ... since its inception. , Just having turned 37, Lissa suffered ... Lissa passed away on August 24, 2012. This event is designed ...
(Date:5/2/2015)... Ticket Down has secured additional inventories of authentic ... event today, Saturday, May 2nd at the MGM Grand Garden ... able to secure tickets for both the actual fight and ... have wanted for more than five years was finally been ... step inside the ring to fight Manny “Pac-Man” Pacquiao in ...
Breaking Medicine News(10 mins):Health News:An Application to Have Fun with Mathematics Was Featured on NewsWatch Television 2Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3
... Supervised exercise was shown to be more effective than ... with peripheral artery disease. The findings from a national ... Association Scientific Sessions meeting. Rhode Island Hospital is one ... Peripheral artery disease (PAD) is a condition in ...
... TUESDAY, Nov. 15 (HealthDay News) -- Entering adulthood in a place ... 21, seems to put women, but not men, at a long-term ... "We want to make sure people know all of the consequences ... an assistant professor in the department of psychiatry at Washington University ...
... News) -- Scientists who identified a gene linked to ... targeted treatments for anxiety disorders. The researchers assessed ... called 7q11.23 duplication syndrome (Dup7q11.23) and Williams-Beuren syndrome (WBS). ... anxiety and specific phobias. It,s caused by extra copies ...
... About half of male breast cancer patients who take the ... effects such as weight gain and sexual dysfunction, which prompts ... to researchers at The University of Texas MD Anderson Cancer ... date of how the estrogen-blocking drug is tolerated in men ...
... have found a way to load more than 2 million ... The breakthrough could speed development of cancer treatments that would ... the inside. The research appears online this week in ... "The breast cancer cells that we studied were so laden ...
... A potential breakthrough in treating late-stage ovarian cancer has ... a peptide that shrinks advanced tumours and improves survival ... "We,re extremely excited about this," said Jim Petrik, a ... who conducted the research with PhD student Nicole Campbell. ...
Cached Medicine News:Health News:Exercise may be better than stents for PAD patients 2Health News:Higher Legal Drinking Age May Mean Safer Lives for Women 2Health News:Higher Legal Drinking Age May Mean Safer Lives for Women 3Health News:Gene Linked to Separation Anxiety 2Health News:Tamoxifen causes significant side effects in male breast cancer patients 2Health News:Tamoxifen causes significant side effects in male breast cancer patients 3Health News:Rice chemists cram 2 million nanorods into single cancer cell 2Health News:Discovery may help fight late-stage ovarian cancer 2
... Spirit is the premium APAP device in ... The AutoSet algorithm responds to the patients ... flow generator stores and reports comprehensive clinical ... AutoSet devices combine integrated humidification and a ...
Paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... System provides the capability to ... middle of surgery while retaining ... incision. The system is also ... for large patients while remaining ...
These retractors, made of rugged Noryl® resin, are pre-sterilized and packaged singly in double peel-pouches for easy delivery to the sterile surgical field....
Medicine Products: